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Key Points
Question
What is the current size of the US pathologist workforce?
Findings
This analysis found that the American Medical Association’s Physician Masterfile listed 21 292 active
pathologists as of June 2019 compared with 12 839 anatomical and clinical pathologists reported by the
Association of American Medical Colleges for 2017 and exceeded all previously published estimates in
the past decade.
Meaning
Accurate physician workforce assessment for all specialties may require a reexamination of the methods
used in producing current and previous estimates.

Abstract
Importance
There is currently no national organization that publishes its data that serves as the authoritative source of
the pathologist workforce in the US. Accurate physician numbers are needed to plan for future health care
service requirements.
Objective
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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To assess the accuracy of current pathologist workforce estimates in the US by examining why divergency
appears in different published resources.
Design, Setting, and Participants
This study examined the American Board of Pathology classification for pathologist primary specialty and
subspecialties and analyzed previously published reports from the following data sources: the Association
of American Medical Colleges (AAMC), the Accreditation Council for Graduate Medical Education
(ACGME), a 2013 College of American Pathologists (CAP) report, a commercially available version of
the American Medical Assoication (AMA) Physician Masterfile, and an unpublished data summary from
June 10, 2019.
Main Outcomes and Measures
Number of physicians classified as pathologists.
Results
The most recent AAMC data from 2017 (published in 2018) reported 12 839 physicians practicing
“anatomic/clinical pathology,” which is a subset of the whole. In comparison, the current AMA Physician
Masterfile, which is not available publicly, listed 21 292 active pathologists in June 2019. The AMA
Physician Masterfile includes all pathologists in 15 subspecialized training areas as identified by the
ACGME. By contrast, AAMC’s data, which derive from the AMA Physician Masterfile data, only count
physicians primarily associated with 3 general categories of pathologists and 1 subspecialty category (ie,
chemical pathology). Thus, the AAMC pathology workforce estimate does not include those whose
principal work is in 11 subspecialty areas, such as blood banking or transfusion medicine, cytopathology,
hematopathology, or microbiology. An additional discrepancy relates to the ACGME residency
(specialties) and fellowship (subspecialties) training programs in which pathologists with training in
dermatopathology appear as dermatologists and pathologists with training in molecular genetic pathology
appear as medical geneticists.
Conclusions and Relevance
This analysis found that most sources reported only select categories of the pathologist workforce rather
than the complete workforce. The discordant nature of reporting may pertain to other medical specialties
that have undergone increased subspecialization during the past 2 decades (eg, surgery and medicine).
Reconsideration of the methods for determining the pathologist workforce and for all workforces in
medicine appears to be needed.

Introduction
Published estimates of the size of the pathology workforce vary considerably. Two analyses1,2 revealed the
challenges in determining the true supply because there are discrepancies in how the data are captured and
the methods used to collect the underlying data. For example, Metter et al1 analyzed the trends in the US
pathology workforce regarding the number of practicing pathologists in the US (and also Canada) between
2007 and 2017 using data from the Association of American Medical Colleges (AAMC) Physician
Workforce Data Books Canadian Medical Association Physician Masterfile for Canada.3 Key findings
were that the current number of pathologists was only 12 839 and the pathology workforce has been
decreasing since at least 2007. These findings conflict with another earlier report2 based on data available
from commercially sold versions of the American Medical Association (AMA) Physician Masterfile
adjusted for physicians who do not permit release of their names (determined by comparison analyses of
physicians listed in state medical board registries and the AMA-released Masterfile). That analysis found
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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that the stated number of pathologists in the US in 2010 was substantially greater (approximately 18 000
full-time equivalents) and projected that, because of the reduction of total number of residents in pathology
programs since 1975 (maximum, 3600 residents),4 the workforce would begin a slow decrease in 2014,
reaching a minimum in approximately 2021.
These data sources can be used to examine the discrepancies that exist between workforce determinations
for pathology and how national organizations compile and report their data. As part of an ongoing, more
extensive analysis of the pathologist workforce, we assessed the accuracy of current pathologist estimates
in the US. In addition, we examined how other organizations’ rules influence pathology workforce counts.

Methods
This analysis examined previously published reports from the following data sources: the AAMC,5 the
Accreditation Council for Graduate Medical Education (ACGME),6 a 2013 College of American
Pathologists (CAP) report,2 a commercially available version of the AMA Physician Masterfile,7 and an
unpublished data summary from June 10, 2019, that was provided by the AMA (courtesy of the AMA’s
Database Products Portfolio Division).
The data from the AAMC have been given in biennial reports since 2006 and are based on the AMA
Physician Masterfile. Since 2000, the AAMC has included additional data from the GME (Graduate
Medical Education) Track, which contains the National GME Census data jointly obtained by the AMA
and the AAMC. The latest ACGME specialties report is from 2018 and is composed of data collected
through 2017. The data from the ACGME are from annual reports from 2002 to the present. The report
that the AMA provided to us responded to our specific request (for all active US pathologists) based on the
subject of this report. We had no access to query any portion of the underlying files from any of these 3
data sources. This is a descriptive analysis, and no statistical analyses were performed.

Results
Collection and dissemination of pathology workforce data involve a web of interconnected entities. The
AMA serves as the lead, responsible for aggregating data from many different sources into its Physician
Masterfile. The ACGME is the principal organization that collects and supplies information on residency
(specialty) and subspecialty (fellowship) programs. For practice specialty, the principal data source is the
ACGME accredited training (residency and fellowship) programs. The GME Track is a resident database
and tracking system introduced in 2000 to assist GME administrators and program directors in the
collection and management of GME data.8 GME Track contains the National GME Census, which the
AAMC and AMA use to reduce duplicative reporting. The American Board of Pathology (ABPath),
although not collecting and reporting workforce data, sets the basic rules for what are considered the
primary categories for certification as pathologists and the secondary categories for the subspecialties of
pathology (eg, dermatopathology).
AAMC Presentation of AMA Data
The AMA Physician Masterfile includes a primary specialty field that lists the principal specialty or
subspecialty of all physicians in the US. The data populating it are principally derived from the ACGME
(residency and fellowship training) but also incorporate information that individual physicians may report
to the AMA. Each physician may only be associated with 1 primary specialty. For consistency, specialty
refers to the field of pathology and subspecialty to any of its parts (eg, dermatopathology). The primary
specialty field has 15 possible unique entries for pathologists (Box), but only 1 is assigned per pathologist
(a subspecialty counts for purposes of this field). The most recently recorded specialty or subspecialty for a
pathologist automatically replaces prior entries. The primary specialty field is used only for workforce
counting.
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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Box.
Specialty Classifications
ABPath
Primary

Anatomic/clinical pathology
Anatomic pathology
Clinical pathology
Anatomic pathology/neuropathology
Subspecialties

Blood banking/transfusion medicine
Chemical pathology
Clinical informatics
Cytopathology
Dermatopathology
Forensic pathology
Hematology
Medical microbiology
Molecular pathology
Neuropathology
Pediatric pathology
AAMC

Anatomic pathology
Anatomic/clinical pathology
Chemical pathology
Clinical pathology
For reporting, the AAMC recognizes only the above
ACGME

Anatomic/clinical pathology
Subspecialties

Blood banking/transfusion medicine
Chemical pathology
Clinical informatics (pathology) (since 2015)
Cytopathology
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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Forensic pathology
Hematology (pathology)
Medical microbiology
Neuropathology
Pediatric pathology
Selective pathology
Ambiguous

Anatomic pathology (legacy designation)
Clinical pathology (legacy designation)
Anatomic pathology/neuropathology (classified as subspecialty neuropathology)
Dermatopathology (multidisciplinary but listed under dermatology)
Molecular genetic pathology (multidisciplinary since at least 2007 but listed under medical
genetics and genomics)
AMA (Based on ACGME)

Anatomic/clinical pathology
Anatomic pathology
Blood banking/transfusion medicine
Chemical pathology
Clinical informatics (pathology) (since 2015)
Clinical pathology
Cytopathology
Dermatopathology (pathology)
Forensic pathology
Hematology (pathology)
Medical microbiology
Molecular genetic pathology (pathology and medical genetics)
Neuropathology
Pediatric pathology
Selective pathology
Abbreviations: AAMC, Association of American Medical Colleges; ABPath, American Board of
Pathology; ACGME, Accreditation Council for Graduate Medical Education; AMA, American
Medical Association.
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Beginning in 2006, the AAMC enumerated pathologists with the descriptor “anatomic/clinical pathology”
to encompass the ABPath categories of anatomic pathology, clinical pathology, anatomic/clinical
pathology, and a single subspecialty (chemical pathology).9,10 The AAMC workforce data do not include
other pathology subspecialties recognized by the AMA and ACGME (Box). Thus, when a pathologist has
a subspecialty other than chemical pathology as their AMA Physician Masterfile primary specialty, the
AAMC does not count that individual. Using the commercially available Masterfile database, which lacks
members who do not wish their names released and which we have corrected by using state medical
registries, we estimated the pathology workforce in 2013 to be 17 968. Review of earlier AAMC reports
showed that these designations have been in place for many years. The rationale for the AAMC method is
not provided. Because the AMA does not report workforce numbers publicly, the only publicly available
data from the AMA Physician Masterfile is that accessible through the AAMC biennial reports.
The AMA Database Products Division provided us with the current numerical summaries of the
pathologist workforce, including all subspecialty categories (Table 1). As of June 10, 2019, the AMA
listed 21 292 active pathologists. On the basis of the same method, the number of active pathologists,
exclusive of semiretired and retired pathologists and residents, was 18 822 in 2011, 19 606 in 2014, and 19
923 in 2017 (courtesy of the AMA Database Products Division from past years). The AAMC, using the
received AMA data (2017 physician data were provided in the most recent 2018 biennial report), listed
only 12 839 active anatomic/clinical pathologists, a subset of the whole (Table 2). The remaining
pathologists were not counted because they fall into pathology subspecialties not included in the AAMC
methods.
Workforce Correlations
The data summary provided by the AMA (Table 1) indicates a count of 7731 pathologists listed by
subspecialty if including selective pathology as a subspecialty (total of all lines minus anatomic pathology,
clinical pathology, and anatomic/clinical pathology). Once this discrepancy was accounted for, the
difference between the AAMC/AMA database and the AMA database alone decreased (8453 vs 7731).
The small variance was plausible considering that the 2 databases were nearly 2 years apart. In addition,
some of the difference may be attributable to how the AAMC, AMA, and insurance companies treat the
status of fellows; fellows in non–ACGME-approved programs can sometimes bill in their own names and
may be considered fully active physicians.
ACGME Misclassification of Some Subspecialties
We found that the annual ACGME Data Resource Books14 anomalously report 2 pathology subspecialist
categories. Dermatopathology and molecular pathology are both subspecialties in which 2 different boards
issue certificates. The ACGME Data Resource Books14 list all dermatopathologist trainees under the
dermatology section in part because it is unknown during training whether the ABPath or American Board
of Dermatology will issue the categorical specialty certificate. Similarly, all molecular pathologists appear
under medical genetics, whether granted by the ABPath or the American Board of Medical Genetics and
Genomics. According to the ABPath, since 2004, a total of 61% of the 1166 dermatopathology trainees
have been pathologists and that 99.8% of the 391 molecular pathology trainees have been pathologists
(R.J., written communication, May 2020).

Discussion
The primary data source for nearly all US physician workforce analyses has been the AMA Physician
Masterfile. The AMA, in maintaining the most definitive physician workforce database in the US, uses
multiple sources to update the Masterfile. For practice specialty, the principal data source is from

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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ACGME-accredited training (residency and fellowship) programs and now, together with the AAMC, the
GME Track. Individuals may at any time also update their AMA record and self-declare themselves to be
pathologists regardless of ACGME-accredited training or ABPath board certification.
The AMA, which in past years published the Physician Characteristics and Distribution in the US,15 does
not currently publish these volumes. The AMA Physician Masterfile data can be licensed from third-party
vendors, but such sets lack physicians who do not want their names released. The vendors also are
authorized to make additional changes and customize the databases responsive to specific requests from
third parties. For example, names of semiretired and retired physicians or active physicians who want
commercial entities not to contact them may be eliminated.
Although the ABPath plays no role in the workforce enumeration, it is the sole organization charged for
setting the examination standards for certification as a pathologist and, in this role, has established the
categories for primary certification and for certification in all major subspecialties. A requirement for all
applicants is to have completed a GME program in pathology or a pathology subspecialty that the
ACGME accredits. All pathologists must obtain a primary certificate in 1 of 4 areas and, with additional
training, may receive additional certificates in 1 or more of the subspecialties listed in the Box.
The ACGME, the AMA (which uses the ACGME classification terms), and the AAMC follow the ABPath
classification closely but not exactly. The ACGME lists pathology in its annual report as a specialty with
10 subspecialties. For the primary specialty, it reports only a single area: anatomic/clinical pathology. It is
uncertain how anatomic pathology and clinical pathology are reported. The ACGME includes selective
pathology as a subspecialty, even though there is no ABPath board certification for these areas.
The AMA uses only 3 of the 4 ABPath areas of primary certification (Box). The AMA also added 1 new
specialty area for which there is no ABPath board certification: selective pathology.
The AAMC does not count the specialty of pathology as a whole but rather enumerates only a single
subset (anatomic/clinical pathology) and, for reporting purposes, includes in this term 4 areas (Box). In
contrast to the ABPath, the AAMC categorizes chemical pathology as a primary area of endeavor and does
not categorize the ABPath’s category of anatomic pathology/neuropathology as a primary specialty. The
AAMC does not report data at the subspecialty level and does not recognize that its data source, the AMA
Physician Masterfile, replaces the pathology primary specialty with the latest reported training. Thus, if an
anatomic/clinical pathologist receives later training in hematopathology, the physician’s primary specialty
field is replaced with the subspecialty hematopathology and the physician is no longer counted by the
AAMC as a pathologist.
The most recent AAMC data16 (through 2017 and published in 2018) reported that the total active
pathologist workforce, which it presents as anatomic/clinical pathology, included 12 839 individuals (9130
in patient care, 388 in teaching, 528 in research, and 2793 categorized as other) (Table 2). This number
contrasts with that reported in a prior analysis2 of workforce supply and in the summary data on
membership that the AMA provided privately to the CAP in the past. The discrepancy was attributable to
an erroneous interpretation made by workforce researchers that the AAMC reports only a subset of the
profession.17 The earlier analysis2 used data that did not come directly from the AMA but rather was from
a commercial vendor whose Masterfile was limited by exclusion of physicians who did not want their
names released. We partially corrected the number by identifying the discrepancies between the AMA
counts and by a detailed count of pathologists listed in searchable individual state medical workforce
databases.
The 40% difference between the AMA count (n = 21 292) and the AAMC’s most recent report (n = 12 839)
is substantial; however, the AAMC count includes only a subset of the pathology workforce. We
recommend that the AAMC or any other organization relying on these data alters how it reports the
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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pathology workforce and includes all individuals in the AMA Physician Masterfile list as pathologists. We
recommend that further previously published reports on pathology workforce based on AAMC
information be reexamined.1,9,10,11,18,19,20
Similarly, the criteria that the AAMC and ACGME use to consider a physician as a pathologist and as a
subspecialist should be reexamined to help clarify their files and reports. The ACGME updates
information about US graduates in training programs for residency and fellowships. In addition,
differences exist among those who partook only in a portion of the residency or fellowship program, those
who graduated from the program, and those who attained board certification.
Metter et al,1 using the AAMC publications, concluded that the US pathologist workforce steadily
decreased from 2007 to 2019. All of us made the same error before recognizing that the AAMC reported
only pathologists with a database category of anatomic/clinical pathology and not the specialty as a whole.
To the surprise of many researchers, the most recent AAMC report11 reported that anatomic/clinical
pathology had the second greatest workforce decrease (8.3%) of any physician specialty between 2012 and
2017 and cited the AMA Physician Masterfile as its source. This was an artifact of the data used for
comparison. In reality, the current AMA Physician Masterfile suggests that the pathologist workforce may
be increasing, although strictly comparable reanalysis of prior years’ data is required to form a conclusion.
Additional research is needed to clarify the current AMA Physician Masterfile method, including the
listing of physicians by self-declaration rather than documented training.
On the basis of the annual ACGME Data Resource Books for academic years 2002 through 2018, an
increasing proportion of pathologist trainees took specialty fellowships during those years and thus have
been excluded from being counted as pathologists by the AAMC method. It is likely that the increasing
percentage (now 97%) of new-in-practice pathologists with subspecialty training has resulted in the
decreasing number of practitioners in the AAMC reports. A future area of work to document the actual
changes in the workforce over multiple periods is needed, specifically comparing numbers of trainees with
subspecialty training entering the profession with those retiring.
We believe that the situation we are describing for pathology may also be occurring in general surgery.
Surgeons with general surgery training can subspecialize in multiple areas (this is why many centers have
subspecialized pathologists). General surgeons can undergo focused fellowship training and subspecialize
in areas such as breast, gastrointestinal, sarcoma, hepatobiliary, and transplant surgery. If a surgeon
undergoes a subspecialty fellowship or lists his or her primary category in the AMA Physician Masterfile
as a breast surgeon, sarcoma surgeon, or hepatobiliary surgeon, how does the AAMC method count them?
Thus, the 2012 AAMC Databook lists 26 314 active general surgeons, but in the 2017 AAMC Databook,
25 042 general surgeons are listed.21 This finding raises the question: Does the change represent a real
decrease, or is it an artifact of the counting and classification methods?
The data from the ACGME reports may also affect the workforce count. Although the ACGME is unable
to distinguish which board will eventually certify each trainee, the organization has historically assigned
all dermatopathologists to dermatology and all molecular pathologists to medical genetics even though,
based on ABPath data, since 2004 a total of 61% of the 1166 dermatopathology trainees and 99.8% of the
391 molecular pathology trainees have been pathologists. We believe it would be more useful and
appropriate to assign these trainees to the specialty in which most are certified.
Accurate workforce numbers have many different applications. At a most basic level, the fee that the
ABPath must pay annually for membership to the American Board of Medical Specialties depends on the
number of pathologists in practice. From the perspective of students considering medicine as a profession
or the type of residency to choose later, questions of specialty viability and job availability are paramount.
Inaccurate or incomplete depictions of the existing or projected supply of physician subspecialties can
misleadingly affect career choices.
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC7366184/?report=printable
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Tools for modeling the workforce are vital when planning for the future demand.13 The AAMC is
developing a modeling tool to improve analytic capabilities with regard to changing physician work
patterns, market saturation and displacement of occupations and select specialties, current shortages and
inefficiencies, and new care delivery and financing models.22 The modeling tool that the CAP developed23
has been useful in evaluating future workforce needs for subspecialties (eg, molecular diagnostics).13
Fraher et al12,24 currently have the only online tool available for public use. It permits workforce
examination at the state level and even at the level of small geographic zones. Such innovative tools are
useful for planning workforce because they are interactive, web based, and user friendly. They give users
the ability to play “what if” scenarios and help estimate where shortages or surpluses will occur. However,
reliable and complete data are imperative if these modeling tools are to provide meaningful insights.
Limitations
This study has limitations. We did not have access to the data behind the reports; thus, individual
physicians listed in each organization’s database could not be identified and matched and inconsistencies
may have occurred. Considerations of privacy and Health Insurance Portability and Accountability Act
may be obstacles to these data becoming available.

Conclusions
Workforce counts are important but often complicated to execute. Without them, intelligent planning for
the future becomes impossible. This current analysis suggests that reevaluation of the current AAMC and
ACGME methods are needed not only for pathology but likely for all medical specialties. We believe that
accurate workforce data are crucial for proper health care service planning.
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Table 1.
American Medical Association Listing of All Pathologists (Without Residents and Retirees)
Specialty

Pathologists, No.

description

Administration Fulltime

Locum Medical Not
tenens

Office-

Other Research S

teaching classified based

hospital

practice

staff
Anatomic

29

257

2

46

15

359

64

116

3

Blood bank

75

130

0

21

183

298

26

22

1

Clinical

1

1

0

0

4

5

2

0

0

Clinical pathology 88

72

0

14

4

102

26

70

2

Dermatopathology 3

124

0

24

159

717

63

9

1

Forensic

23

96

0

12

155

441

159

3

3

4

221

1

38

439

711

44

10

3

3

22

1

21

169

87

7

9

2

6

18

0

7

34

37

3

6

1

Neuropathology

5

60

1

37

121

148

10

49

8

Chemical

4

1

0

2

7

9

4

2

1

Cytopathology

3

263

0

59

488

769

30

3

3

Pediatric

0

61

0

13

96

86

7

1

4

331

2394

19

328

1761

5705

641

342

2

NA

128

NA

44

485

431

20

4

1

pathology

informatics
a
(pathology)

pathology
Hematology
(pathology)
Molecular
(genetic)
pathology
Medical
microbiology

pathology

pathology
Anatomic/clinical
pathology
Selective
b
Abbreviation: NA, not applicable.
a

The American Board of Pathology and a second American Board may certify the same subspecialty. The numbers
provided are only for those candidates the American Board of Pathology has certified.
b
Selective pathology is not an American Board of Pathology–certified subspecialty but indicates when a pathologist
has successfully completed a recognized fellowship training program in a subspecialty (eg, general surgical pathology
or gastrointestinal surgical pathology) that the Accreditation Council for Graduate Medical Education reviews.
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Table 2.
Sources of Pathologist Workforce Numbers
Source

Pathologists,

Date of

Data

No.

data

source

Comment

collection
AMA, 2019

21 292

June 2019 AMA

Data private

AMA Physician

19 222

October

AMA

Masterfile available through database licensee

2018

licensee

2017

AAMC

Released biennially. omits all pathologists

and

with specialty boards

Masterfile, commercially
available 2018
11
AAMC report and
1
Metter et al, 2019

12 839

AMA
12
Fraher et al

Approximately June 2013 Unclear

Likely from AMA commercial datafile.

17 700

assumes an approximately 2% growth per
year

2
Robboy et al, 2013 and
13
Robboy et al, 2015

17 986

December Multiple Based on AMA commercially available
2010

Masterfile emended after state medical boards
comparative review

Abbreviations: AAMC, Association of American Medical Colleges; AMA, American Medical Association.
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